Search Results - Cesar Libanati
- Showing 1 - 5 results of 5
-
1
Fracture Risk in Men and Women With Vertebral Fractures Identified Opportunistically on Routine Computed Tomography Scans and Not Treated for Osteoporosis: An Observational Cohort... by Michael Kriegbaum Skjødt, Joeri Nicolaes, Christopher Dyer Smith, Kim Rose Olsen, Cyrus Cooper, Cesar Libanati, Bo Abrahamsen
Published in JBMR Plus (2023-05-01)Get full text
Article -
2
Romosozumab improves lumbar spine BMD and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the ARCH trial by Jacques P. Brown, Arkadi Chines, Roland Chapurlat, Joseph Foldes, Xavier Nogues, Roberto Civitelli, Tobias De Villiers, Fabio Massari, Cristiano Zerbini, Wenjing Yang, Chris Recknor, Cesar Libanati
Published in Bone Reports (2020-10-01)Get full text
Article -
3
The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study by Piet Geusens, Mary Oates, Akimitsu Miyauchi, Jonathan D Adachi, Marise Lazaretti‐Castro, Peter R Ebeling, Carlos Augusto Perez Niño, Cassandra E Milmont, Andreas Grauer, Cesar Libanati
Published in JBMR Plus (2019-10-01)Get full text
Article -
4
Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals by Felicia Cosman, Cesar Libanati, Cynthia Deignan, Zhigang Yu, Zhenxun Wang, Serge Ferrari, Jens‐Erik Beck Jensen, Pilar Peris, Francesco Bertoldo, Eric Lespessailles, Eric Hesse, Steven R Cummings
Published in JBMR Plus (2021-11-01)Get full text
Article -
5
